World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
46887
World Ranking
5745
National Ranking
3088

William I. Bensinger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where William I. Bensinger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 474 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

William I. Bensinger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where William I. Bensinger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

William I. Bensinger is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong emphasis on the subfields of Hematology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, and Infectious Diseases.

The scientist's work centers around several main topics including:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • HIV/AIDS Drug Development and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • Peptidase Inhibition and Analysis
  • Chronic Lymphocytic Leukemia Research
  • Cancer Treatment and Pharmacology

William I. Bensinger has contributed to numerous publications in various journals, with frequent contributions to venues such as Blood, Clinical Lymphoma Myeloma & Leukemia, Journal of Clinical Oncology, Leukemia, and eJHaem.

Selected recent papers include:

  • Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011), 2020, Journal of Clinical Oncology
  • REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM), 2020, Blood
  • A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma, 2020, Leukemia
  • Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial, 2022, The Lancet Haematology
  • Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients, 2021, British Journal of Cancer

Frequent collaborators of William I. Bensinger include Suzanne Lentzsch, Nizar J. Bahlis, Sascha A. Tuchman, Darrell White, and Brea Lipe.

Best Publications

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

    Rainer Storb;H. Joachim Deeg;John Whitehead;Frederick Appelbaum

  • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

    William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift

  • Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

    Ricardo Spielberger;Patrick Stiff;William Bensinger;Teresa Gentile

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Antigen CD34+ marrow cells engraft lethally irradiated baboons.

    R J Berenson;R G Andrews;W I Bensinger;D Kalamasz

  • Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

    C Anasetti;D Amos;P G Beatty;F R Appelbaum

  • Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor

    WI Bensinger;CH Weaver;FR Appelbaum;S Rowley

  • Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

    W Bensinger;F Appelbaum;S Rowley;R Storb

  • Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma.

    RJ Berenson;WI Bensinger;RS Hill;RG Andrews

  • Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.

    RA Clift;CD Buckner;FR Appelbaum;SI Bearman

  • Marrow Transplantation for the Treatment of Chronic Myelogenous Leukemia

    E D Thomas;R A Clift;A Fefer;F R Appelbaum

  • Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.

    R Storb;HJ Deeg;M Pepe;F Appelbaum

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

  • Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

    Mahmoud al-Jurf;Mahmoud al-Jurf;Francisco Aranha;Francisco Aranha;Claudio Annasetti;Jane F. Apperley;Jane F. Apperley

  • Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

    Mary E. D. Flowers;Pablo M. Parker;Laura J. Johnston;Alice V. B. Matos

  • Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.

    Jan Storek;Monja A. Dawson;Barry Storer;Terry Stevens-Ayers

  • Marrow Transplantation for Chronic Myeloid Leukemia: A Randomized Study Comparing Cyclophosphamide and Total Body Irradiation With Busulfan and Cyclophosphamide

    RA Clift;CD Buckner;ED Thomas;WI Bensinger

  • Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

    David G. Maloney;Arthur J. Molina;Firoozeh Sahebi;Keith E. Stockerl-Goldstein

Frequent Co-Authors

Oliver W. Press
Oliver W. Press University of Washington
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
Buckner Cd
Buckner Cd National Cancer Institute
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Claudio Anasetti
Claudio Anasetti Fred Hutchinson Cancer Research Center
Kristine Doney
Kristine Doney Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine, there are a variety of related online degrees and career pathways that can support your professional growth. Many students begin their healthcare journey through nursing, and for those looking for flexibility in admissions, there are several nursing schools that don't require teas or hesi exams. This can help reduce barriers for prospective students seeking a fast start in the field.

For individuals eager to move into healthcare leadership, earning an online healthcare management degree can lead to roles in administration and operations. Nurses with an associate’s degree can further their expertise and become nurse practitioners by enrolling in adn to fnp programs, which are designed as bridge programs for career advancement.

Lastly, if you’re passionate about preventative care and healthy living, consider a nutrition degree online. This pathway opens doors to careers in wellness, research, or health education, complementing a background in medicine and providing diverse opportunities within the healthcare sector.

Best Scientists Citing William I. Bensinger

Trending Scientists

Recently Published Articles